Pinealon

$
Bioregulator / Longevity

Bioregulator peptide with limited clinical evidence

Pinealon is a short EDR tripeptide discussed for neuroprotection, cognitive aging, and bioregulator concepts.

Most support is preclinical, small, regional, or mechanistic. The guide should not present it as a proven dementia, sleep, DNA-repair, or longevity therapy. Treat Pinealon as experimental. Ask whether evidence uses objective cognitive testing, sleep metrics, biomarkers, or simply subjective clarity.

Classification details

  • Pinealon is a synthetic tripeptide often grouped with Khavinson-style peptide bioregulators.
  • It is usually discussed in neuro-aging and cognitive-repair contexts rather than as a single-receptor drug.
  • Pinealon is a short synthetic tripeptide bioregulator associated with neuro/cognitive and longevity claims. It is low-evidence, not a proven brain-aging therapy.
  • Proposed mechanisms include gene-expression modulation, antioxidant effects, peptide bioregulation, and neuronal-protection signaling. These are broad hypotheses with limited direct human validation.

Sections 3-9, Works Cited, and the complete research guide require Full Access.

Get FULL Access and Guide
EpithalonDSIP / EmideltideSemax

Educational reference only — not medical advice. Peptides discussed are not approved for human use in many jurisdictions and may be research-use-only. Consult a qualified clinician before use. Some detailed sections require full PepGuide access.